This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical & Medical Affairs - Classic

Cutting-edge approaches to trial and study design, technology, sourcing, data disclosure and medical communications.

Articles & Video

Showing 2 of 2 articles & video

Decentralized clinical trials

REPORT: Impacts of Decentralized Clinical Trials 2021

Explore the Clinical Trials Series global research study into adoption and impacts on patients, speed and cost of decentralized clinical trials.

Clinical trials

Clinical Trials Content Library: Whitepapers and Reports Collection

Explore our collection of exclusive whitepapers and reports covering the hottest topics in clinical trials with one simple registration.

Clinical Insider

Informed consent still the major challenge for CROs based on new study

Gaining informed consent for participants is a major challenge for the drug trials industry according to analysis suggesting such issues are the most common problem flagged by US FDA inspectors.

Using clinicaltrials.gov more effectively would aid clinical evidence system, say researchers

Selective reporting and bias are undermining the integrity of the clinical evidence system say the authors of new analysis who suggested changes to ClinicalTrials.gov would have a positive impact.

New Association of Diversity in Clinical Trials portal attracts 130 new members in weeks

The Association of Diversity in Clinical Trials (AOD) has launched a membership portal designed to make US drug research more inclusive.

Clinical Insider

Frontage buys Accelera’s clinical bioanalysis biz in EU expansion

Frontage Laboratories has acquired Accelera Srl’s bioanalytical and drug metabolism and pharmacokinetics businesses.

GHO-backed Velocity adds sites in Poland and Germany

UK site management organization Velocity Clinical Research has expanded operations in Europe, adding five sites in Poland through the acquisition of KO-MED Centra Kliniczne.

Clinical Insider

CRO deal making dominated by skills and reach focused mergers in 2023

CRO sector M&A activity in 2023 reflected growing pharmaceutical industry desire for contractors with broader skills, increased capacity and expanded geographic reach based on deals done to date.

Clinical Insider

Kohlberg completes Worldwide Clinical Trials deal and talks expansion

Private equity firm Kohlberg & Co has taken a majority stake in Worldwide Clinical Trials following a “recapitalization” designed to fund expansion.

Clinical Insider

hVIVO unveils $21.5m manufacturing and trial contract for RSV model

UK trials contractor hVIVO has signed a £16.8 million ($21.5 million) full-service contract with a “top five global pharmaceutical client” to test a developmental respiratory syncytial virus (RSV) antiviral.

Clinical Insider

Recipharm, Oz-UK join forces to advance ‘green’ inhalers

Recipharm has partnered with Oz-UK to develop and manufacture green pressurized metered dose inhalers (pMDIs).

Clinical Insider

Novartis invests in generative AI tech firm Yseop

Swiss drug maker Novartis has invested in trial document automation services firm Yseop joining existing backers like Eli Lilly and NextStage AM.

Clinical Insider

CEPI adds Charles River Labs to list of firms preparing for next pandemic

The Coalition for Epidemic Preparedness Innovations (CEPI) has added Charles River Laboratories to the list of firms it works with.

Clinical Insider

BC Platforms buys Medexprim to expand RWD access

BC Platforms has acquired real-world data (RWD) firm Medexprim, citing a desire to provide biopharma partners with access to clinical and imaging data assets across Europe.

Clinical Insider

QPS sells neuropharma unit and expands Missouri lab

QPS Holdings has sold its neuropharmacology business to Danish preclinical contractor, Scantox and expanded its clinical lab in Springfield, Missouri.

Clinical Insider

Ampersand invests in Julius Clinical Research

Private equity firm Ampersand Capital Partners has invested in Academia-focused CRO, Julius Clinical Research.

AZ to make digital trial tech available to CRO through new business

AstraZeneca has entered the trial services space through a new company that will make its digital tech available to CROs.

Clinical Insider

Dare Bioscience extends US trial deal with Premier Research

North Carolina-based Fortrea saw revenue grow in the third quarter - its second quarter as an independent clinical research organization (CRO) - driven by growth of its clinical trial and services divisions.

Clinical Insider

Fortrea sees revenue grow in Q3 and 'shapes' to meet changing demands

North Carolina-based Fortrea saw revenue grow in the third quarter - its second quarter as an independent clinical research organization (CRO) - driven by growth of its clinical trial and services divisions.

Legend looks to Belgium plant opening as CAR-T expansions loom

A facility in Ghent, Belgium will begin clinical supply for an expected increase in patients gaining access to CAR-T therapy Carvykti, says Legend Biotech.

Clinical Insider

Ichor Life Sciences sets up clinical trials business

Longevity firm Ichor Life Sciences has launched a clinical trial services business citing market demand for bespoke drug development support.

Clinical Insider

Archimed-based Symbio merges with Proinnovera to form dermatology CRO

US-based Symbio Research and German CRO Proinnovera have merged to form Symbio Proinnovera, a dermatology-focused clinical research organization.